OXPAM 15 MG
OXAZEPAM : 15 MG · DIN 00414255 · BIOMED PHARMA
Health Canada status: DORMANT
What is OXPAM?
OXPAM 15 MG contains OXAZEPAM : 15 MG. It is listed in the Health Canada Drug Product Database under DIN 00414255, held by BIOMED PHARMA, supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 04-Aug-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is OXPAM used for?
OXPAM (oxazepam tablets) is indicated for the short-term symptomatic relief of excessive anxiety and tension in patients with anxiety neurosis. OXPAM also is indicated for relieving the symptoms of acute alcoholic withdrawal, including acute agitation and impending delirium tremens.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00414255 |
|---|---|
| Brand name | OXPAM |
| Generic / active ingredient | OXAZEPAM : 15 MG |
| Manufacturer | BIOMED PHARMA |
| Strength | 15 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | TARGETED SUBSTANCES (CDSA IV) |
| ATC code | N05BA04 OXAZEPAM |
| AHFS class | 28:24.08 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 04-Aug-2017 |
| Original market date | 1979-12-31 00:00:00 |
How is it stored and handled?
null
How is it supplied?
Bottles of 100 and 1000
What can be used instead?
Other Canadian products sharing ATC code N05BA04 OXAZEPAM. 9 of 31 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-OXAZEPAM | 10 MG | TABLET | APOTEX INC | MARKETED | DIN 00402680 |
| APO-OXAZEPAM | 15 MG | TABLET | APOTEX INC | MARKETED | DIN 00402745 |
| APO-OXAZEPAM | 30 MG | TABLET | APOTEX INC | MARKETED | DIN 00402737 |
| PRO-OXAZEPAM | 10 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 00497754 |
| PRO-OXAZEPAM | 15 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 00497762 |
| PRO-OXAZEPAM | 30 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 00497770 |
| RIVA-OXAZEPAM | 10 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED | DIN 00568392 |
| RIVA-OXAZEPAM | 15 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED | DIN 00568406 |
| RIVA-OXAZEPAM | 30 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED | DIN 00568414 |
| BIO-OXAZEPAM | 10 MG | TABLET | BIOMED PHARMA | CANCELLED POST MARKET | DIN 02247177 |
Who else supplies OXAZEPAM worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OXAZEPAM appears in 158 registered pack listings across 8 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
This DIN is dormant — it holds a Health Canada authorization but is not currently being marketed in Canada, so it cannot simply be ordered from Canadian stock. Where a patient need exists, supply may be possible through exceptional importation or the Special Access Programme, subject to Health Canada's requirements and the prescriber's application. Nexara can advise on the route and on marketed alternatives.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.